Cargando…

Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States

SIMPLE SUMMARY: Elevated β(2)-microglobulin (β2m) serum levels cause serious complications in patients on long-term kidney dialysis by depositing in the form of amyloid fibrils in the osteoarticular system. Recently, a hereditary systemic amyloidosis was discovered, caused by a naturally occurring D...

Descripción completa

Detalles Bibliográficos
Autores principales: Bulyáki, Éva, Kun, Judit, Molnár, Tamás, Papp, Alexandra, Micsonai, András, Vadászi, Henrietta, Márialigeti, Borbála, Kovács, Attila István, Gellén, Gabriella, Yamaguchi, Keiichi, Lin, Yuxi, So, Masatomo, Józsi, Mihály, Schlosser, Gitta, Lee, Young-Ho, Liliom, Károly, Goto, Yuji, Kardos, József
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614874/
https://www.ncbi.nlm.nih.gov/pubmed/34827190
http://dx.doi.org/10.3390/biology10111197
_version_ 1784603966850465792
author Bulyáki, Éva
Kun, Judit
Molnár, Tamás
Papp, Alexandra
Micsonai, András
Vadászi, Henrietta
Márialigeti, Borbála
Kovács, Attila István
Gellén, Gabriella
Yamaguchi, Keiichi
Lin, Yuxi
So, Masatomo
Józsi, Mihály
Schlosser, Gitta
Lee, Young-Ho
Liliom, Károly
Goto, Yuji
Kardos, József
author_facet Bulyáki, Éva
Kun, Judit
Molnár, Tamás
Papp, Alexandra
Micsonai, András
Vadászi, Henrietta
Márialigeti, Borbála
Kovács, Attila István
Gellén, Gabriella
Yamaguchi, Keiichi
Lin, Yuxi
So, Masatomo
Józsi, Mihály
Schlosser, Gitta
Lee, Young-Ho
Liliom, Károly
Goto, Yuji
Kardos, József
author_sort Bulyáki, Éva
collection PubMed
description SIMPLE SUMMARY: Elevated β(2)-microglobulin (β2m) serum levels cause serious complications in patients on long-term kidney dialysis by depositing in the form of amyloid fibrils in the osteoarticular system. Recently, a hereditary systemic amyloidosis was discovered, caused by a naturally occurring D76N β2m mutant exhibiting normal serum levels and a distinct, visceral deposition pattern. D76N β2m showed a structure remarkably similar to the wild-type (WT) protein, albeit with decreased thermodynamic stability and increased amyloidogenicity. Despite the extensive research, the molecular bases of the aberrant aggregation of β2m in vivo remains elusive. Here, using a variety of biophysical techniques, we investigated the role of the pathogenic D76N mutation in the amyloid formation of β2m by point mutations affecting the stabilizing ion-pairs of β2m. We found that, relative to WT β2m, the exceptional amyloidogenicity of the pathogenic D76N β2m variant is realized by the synergy of diverse effects of destabilized native structure, higher sensitivity to negatively charged amphiphilic molecules and polyphosphate, more effective fibril nucleation, higher conformational stability of fibrils, and elevated affinity for extracellular matrix proteins. Understanding the underlying molecular mechanisms might help to find target points for effective treatments against diseases associated with the deleterious aggregation of proteins. ABSTRACT: β(2)-microglobulin (β2m), the light chain of the MHC-I complex, is associated with dialysis-related amyloidosis (DRA). Recently, a hereditary systemic amyloidosis was discovered, caused by a naturally occurring D76N β2m variant, which showed a structure remarkably similar to the wild-type (WT) protein, albeit with decreased thermodynamic stability and increased amyloidogenicity. Here, we investigated the role of the D76N mutation in the amyloid formation of β2m by point mutations affecting the Asp76-Lys41 ion-pair of WT β2m and the charge cluster on Asp38. Using a variety of biophysical techniques, we investigated the conformational stability and partial unfolding of the native state of the variants, as well as their amyloidogenic propensity and the stability of amyloid fibrils under various conditions. Furthermore, we studied the intermolecular interactions of WT and mutant proteins with various binding partners that might have in vivo relevance. We found that, relative to WT β2m, the exceptional amyloidogenicity of the pathogenic D76N β2m variant is realized by the deleterious synergy of diverse effects of destabilized native structure, higher sensitivity to negatively charged amphiphilic molecules (e.g., lipids) and polyphosphate, more effective fibril nucleation, higher conformational stability of fibrils, and elevated affinity for extracellular components, including extracellular matrix proteins.
format Online
Article
Text
id pubmed-8614874
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86148742021-11-26 Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States Bulyáki, Éva Kun, Judit Molnár, Tamás Papp, Alexandra Micsonai, András Vadászi, Henrietta Márialigeti, Borbála Kovács, Attila István Gellén, Gabriella Yamaguchi, Keiichi Lin, Yuxi So, Masatomo Józsi, Mihály Schlosser, Gitta Lee, Young-Ho Liliom, Károly Goto, Yuji Kardos, József Biology (Basel) Article SIMPLE SUMMARY: Elevated β(2)-microglobulin (β2m) serum levels cause serious complications in patients on long-term kidney dialysis by depositing in the form of amyloid fibrils in the osteoarticular system. Recently, a hereditary systemic amyloidosis was discovered, caused by a naturally occurring D76N β2m mutant exhibiting normal serum levels and a distinct, visceral deposition pattern. D76N β2m showed a structure remarkably similar to the wild-type (WT) protein, albeit with decreased thermodynamic stability and increased amyloidogenicity. Despite the extensive research, the molecular bases of the aberrant aggregation of β2m in vivo remains elusive. Here, using a variety of biophysical techniques, we investigated the role of the pathogenic D76N mutation in the amyloid formation of β2m by point mutations affecting the stabilizing ion-pairs of β2m. We found that, relative to WT β2m, the exceptional amyloidogenicity of the pathogenic D76N β2m variant is realized by the synergy of diverse effects of destabilized native structure, higher sensitivity to negatively charged amphiphilic molecules and polyphosphate, more effective fibril nucleation, higher conformational stability of fibrils, and elevated affinity for extracellular matrix proteins. Understanding the underlying molecular mechanisms might help to find target points for effective treatments against diseases associated with the deleterious aggregation of proteins. ABSTRACT: β(2)-microglobulin (β2m), the light chain of the MHC-I complex, is associated with dialysis-related amyloidosis (DRA). Recently, a hereditary systemic amyloidosis was discovered, caused by a naturally occurring D76N β2m variant, which showed a structure remarkably similar to the wild-type (WT) protein, albeit with decreased thermodynamic stability and increased amyloidogenicity. Here, we investigated the role of the D76N mutation in the amyloid formation of β2m by point mutations affecting the Asp76-Lys41 ion-pair of WT β2m and the charge cluster on Asp38. Using a variety of biophysical techniques, we investigated the conformational stability and partial unfolding of the native state of the variants, as well as their amyloidogenic propensity and the stability of amyloid fibrils under various conditions. Furthermore, we studied the intermolecular interactions of WT and mutant proteins with various binding partners that might have in vivo relevance. We found that, relative to WT β2m, the exceptional amyloidogenicity of the pathogenic D76N β2m variant is realized by the deleterious synergy of diverse effects of destabilized native structure, higher sensitivity to negatively charged amphiphilic molecules (e.g., lipids) and polyphosphate, more effective fibril nucleation, higher conformational stability of fibrils, and elevated affinity for extracellular components, including extracellular matrix proteins. MDPI 2021-11-17 /pmc/articles/PMC8614874/ /pubmed/34827190 http://dx.doi.org/10.3390/biology10111197 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bulyáki, Éva
Kun, Judit
Molnár, Tamás
Papp, Alexandra
Micsonai, András
Vadászi, Henrietta
Márialigeti, Borbála
Kovács, Attila István
Gellén, Gabriella
Yamaguchi, Keiichi
Lin, Yuxi
So, Masatomo
Józsi, Mihály
Schlosser, Gitta
Lee, Young-Ho
Liliom, Károly
Goto, Yuji
Kardos, József
Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States
title Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States
title_full Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States
title_fullStr Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States
title_full_unstemmed Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States
title_short Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States
title_sort pathogenic d76n variant of β(2)-microglobulin: synergy of diverse effects in both the native and amyloid states
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614874/
https://www.ncbi.nlm.nih.gov/pubmed/34827190
http://dx.doi.org/10.3390/biology10111197
work_keys_str_mv AT bulyakieva pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT kunjudit pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT molnartamas pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT pappalexandra pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT micsonaiandras pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT vadaszihenrietta pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT marialigetiborbala pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT kovacsattilaistvan pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT gellengabriella pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT yamaguchikeiichi pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT linyuxi pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT somasatomo pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT jozsimihaly pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT schlossergitta pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT leeyoungho pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT liliomkaroly pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT gotoyuji pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates
AT kardosjozsef pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates